The prevalence of PD-L1 expression in tumor cells was 5% in chromophobe RCC, 10% in papillary RCC, 30% in tRCC, and 20% in collecting duct carcinoma. The gene discussed is CD274; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.